Mirae Asset Nifty 500 Healthcare ETF vs Nippon India Nifty Pharma ETF
Direct Plan where a fund has one, Growth option · Data as on 30-10-2026
Mirae Asset Nifty 500 Healthcare ETF is an ETF fund and Nippon India Nifty Pharma ETF is a mutual fund. Mirae Asset Nifty 500 Healthcare ETF charges 0.35% a year and Nippon India Nifty Pharma ETF 0.23%. Their portfolios overlap 69.0%: they hold 20 of the same securities.
Mirae Asset Nifty 500 Healthcare ETF
ETF
- Expense ratio
- 0.35%
- NAV
- ₹21.44
Which is better, Mirae Asset Nifty 500 Healthcare ETF or Nippon India Nifty Pharma ETF? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Nippon India Nifty Pharma ETF costs less: 0.23% a year against 0.35%.
- Nippon India Nifty Pharma ETF fell less in its worst fall since 11-02-2026: −6.9% against −9.6%.
- Nippon India Nifty Pharma ETF holds more in large companies: 46.3% of the fund in large caps against 36.0%.
- Nippon India Nifty Pharma ETF is the larger fund: ₹1,736 Cr against ₹15 Cr.
- Their portfolios overlap 69.0%: 20 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Mirae Asset Nifty 500 Healthcare ETF | Nippon India Nifty Pharma ETF |
|---|---|---|
| Fund house | Mirae Asset Mutual Fund | Nippon India Mutual Fund |
| Category | ETF | Not available |
| AUM | ₹15 Cr (30-09-2026) | ₹1,736 Cr (30-09-2026) |
| NAV | ₹21.44 | ₹27.89 (Direct) |
| Expense ratio (Direct) | Not available | 0.23% |
| Expense ratio (Regular) | Not available | Not available |
| Riskometer | Very High | Not available |
| Benchmark | Nifty500 Healthcare TRI | Not available |
| Launch date | Not available | Not available |
| Minimum investment | On exchange in multiple of 1 unit. With AMC: In multiples of 5,000 units | Not available |
| Lock in | None | Not available |
| Fund managers | Ekta Gala, amp, Ritesh Patel | Not available |
| Exit load | NIL | Not available |
Mirae Asset Nifty 500 Healthcare ETF vs Nippon India Nifty Pharma ETF: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Mirae Asset Nifty 500 Healthcare ETF | +1.43% | −0.66% | +12.95% | -- | -- | -- | -- |
| Nippon India Nifty Pharma ETF (Direct) | +2.58% | +2.95% | +16.84% | +22.08% | +22.94% | +14.91% | -- |
Mirae Asset Nifty 500 Healthcare ETF vs Nippon India Nifty Pharma ETF: Year-wise Returns
| Year | Mirae Asset Nifty 500 HealthcareMirae Asset Nifty 500 Healthcare ETF | Nippon India Nifty PharmaNippon India Nifty Pharma ETF |
|---|---|---|
| 2026to date | -- | +19.82% |
| 2025 | -- | −2.46% |
| 2024 | -- | +39.59% |
| 2023 | -- | +34.44% |
| 2022 | -- | −10.86% |
Mirae Asset Nifty 500 Healthcare ETF vs Nippon India Nifty Pharma ETF: Rolling Returns
Every holding period of both funds, against Nifty500 Healthcare TRI, the benchmark of Mirae Asset Nifty 500 Healthcare ETF
Mirae Asset Nifty 500 Healthcare ETF vs Nippon India Nifty Pharma ETF: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Mirae Asset Nifty 500 Healthcare ETF | Nippon India Nifty Pharma ETF (Direct) |
|---|---|---|
| Return (CAGR) | +23.46% | +13.22% |
| Standard deviation | 14.16% | 15.07% |
| Sharpe ratio | 1.29 | 0.50 |
| Sortino ratio | 1.90 | 0.72 |
| Maximum drawdown | −9.6% (23-10-2026) | −21.0% (13-03-2023) |
| Beta | 1.00 | 1.00 |
| Alpha | −0.22% | −0.26% |
From daily NAVs, 11-02-2026 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Mirae Asset Nifty 500 Healthcare ETF
Nippon India Nifty Pharma ETF (Direct)
Nifty500 Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Mirae Asset Nifty 500 Healthcare ETF | −9.6% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.0% |
| Nippon India Nifty Pharma ETF (Direct) | −6.9% | 31-08-2026 | 23-10-2026 | Not yet | -- | −0.3% |
| Nifty500 Healthcare TRI | −9.6% | 23-09-2026 | 23-10-2026 | Not yet | -- | −2.9% |
From daily values since 11-02-2026, the first day every fund has.
Mirae Asset Nifty 500 Healthcare ETF vs Nippon India Nifty Pharma ETF: Portfolio Overlap
From each fund's latest monthly portfolio: Mirae Asset Nifty 500 Healthcare ETF, September 2026; Nippon India Nifty Pharma ETF, September 2026
Holdings in common
- Overlap
- 69.0%
- Held by both
- 20
- Only in Mirae Asset Nifty 500 Healthcare ETF
- 24
- Only in Nippon India Nifty Pharma ETF
- 0
| Security | % of Mirae Asset Nifty 500 Healthcare ETF | % of Nippon India Nifty Pharma ETF |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.13% | 19.50% |
| Divi's Laboratories Ltd. | 8.76% | 11.97% |
| Laurus Labs Ltd. | 5.72% | 7.82% |
| Cipla Ltd. | 5.62% | 7.68% |
| Dr. Reddy's Laboratories Ltd. | 5.58% | 7.62% |
| Torrent Pharmaceuticals Ltd. | 5.24% | 7.16% |
| Lupin Ltd. | 3.66% | 5.00% |
| Aurobindo Pharma Ltd. | 3.43% | 4.69% |
| Glenmark Pharmaceuticals Ltd. | 2.61% | 3.56% |
| Alkem Laboratories Ltd. | 2.31% | 3.16% |
| Zydus Lifesciences Ltd. | 2.14% | 2.92% |
| Mankind Pharma Ltd. | 2.10% | 2.88% |
| IPCA Laboratories Ltd. | 1.98% | 2.71% |
| Biocon Ltd. | 1.91% | 2.62% |
| Gland Pharma Ltd. | 1.71% | 2.34% |
| Sai Life Sciences Ltd. | 1.56% | 2.14% |
| Wockhardt Ltd. | 1.30% | 1.77% |
| Ajanta Pharma Ltd. | 1.22% | 1.67% |
| Abbott India Ltd. | 1.04% | 1.43% |
| Piramal Pharma Ltd. | 0.95% | 1.30% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 69.0% means 69.0% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Mirae Asset Nifty 500 Healthcare ETF
| Security | % of fund |
|---|---|
| Apollo Hospitals Enterprise Ltd. | 6.24% |
| Max Healthcare Institute Ltd. | 5.13% |
| Fortis Healthcare Ltd. | 2.98% |
| Krishna Institute of Medical Sciences Ltd. | 1.48% |
| Aster DM Quality Care Ltd. | 1.38% |
Largest holdings only in Nippon India Nifty Pharma ETF
Every holding of this fund is also held by the other.
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Mirae Asset Nifty 500 Healthcare ETF | Nippon India Nifty Pharma ETF |
|---|---|---|
| Equity | 100.0% | 99.9% |
| Debt | 0.0% | 0.0% |
| Cash and others | 0.0% | 0.1% |
Market cap of stocks
| Market cap | Mirae Asset Nifty 500 Healthcare ETF | Nippon India Nifty Pharma ETF |
|---|---|---|
| Large Cap | 36.0% | 46.3% |
| Mid Cap | 45.6% | 46.1% |
| Small Cap | 18.3% | 7.5% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Mirae Asset Nifty 500 Healthcare ETF | Nippon India Nifty Pharma ETF |
|---|---|---|
| Pharmaceuticals & Biotechnology | 77.8% | 99.9% |
| Healthcare Services | 21.7% | 0.0% |
| Healthcare Equipment & Supplies | 0.5% | 0.0% |
The six largest sectors of each fund's stocks, % of the fund.
Mirae Asset Nifty 500 Healthcare ETF vs Nippon India Nifty Pharma ETF: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Mirae Asset Nifty 500 Healthcare ETF | Nippon India Nifty Pharma ETF |
|---|---|---|
| Total expense ratio (Direct) | Not available | 0.23% |
| Base expense ratio (Direct) | 0.00% | 0.18% |
| Base expense ratio (Regular) | 0.16% | 0.00% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
Mirae Asset Nifty 500 Healthcare ETF vs Nippon India Nifty Pharma ETF: Frequently Asked Questions
What is the difference between Mirae Asset Nifty 500 Healthcare ETF and Nippon India Nifty Pharma ETF?
Mirae Asset Nifty 500 Healthcare ETF is an ETF fund, Nippon India Nifty Pharma ETF is a mutual fund, run by Mirae Asset Mutual Fund and Nippon India Mutual Fund. Their portfolios overlap 69.0%. Mirae Asset Nifty 500 Healthcare ETF charges 0.35% a year and Nippon India Nifty Pharma ETF 0.23%.
Which has the lower expense ratio, Mirae Asset Nifty 500 Healthcare ETF or Nippon India Nifty Pharma ETF?
Nippon India Nifty Pharma ETF charges less: 0.23% a year against 0.35%. These are the total expense ratios reported to AMFI.
How much do Mirae Asset Nifty 500 Healthcare ETF and Nippon India Nifty Pharma ETF overlap?
69.0%. They hold 20 of the same securities, the largest shared ones being SUNPHARMA, DIVISLAB, LAURUSLABS. From each fund's latest monthly portfolio.
Can I invest in both Mirae Asset Nifty 500 Healthcare ETF and Nippon India Nifty Pharma ETF?
Yes. 69.0% of each fund's money sits in the same holdings, so a large part of the two investments would move together.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.